References
- Coronavirus Pandemic (COVID-19) [Internet]. 2022. Available from: https://ourworldindata.org/coronavirus.
- Liang M, Gao L, Cheng C, et al. Efficacy of face mask in preventing respiratory virus transmission: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;36:101751.
- Nussbaumer-Streit B, Mayr V, Dobrescu AI, et al. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database Syst Rev. 2020;9(9):Cd013574.
- Flaxman S, Mishra S, Gandy A, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584(7820):257–261.
- Park M, Cook AR, Lim JT, et al. A systematic review of COVID-19 epidemiology based on current evidence. J Clin Med. 2020;9(4):967.
- Han E, Tan MMJ, Turk E, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia pacific and Europe. Lancet. 2020;396(10261):1525–1534.
- Onyeaka H, Anumudu CK, Al-Sharify ZT, et al. COVID-19 pandemic: a review of the global lockdown and its far-reaching effects. Sci Prog. 2021;104(2):368504211019854.
- Okada H, Kuhn C, Feillet H, et al. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update. Clin Exp Immunol. 2010;160(1):1–9.
- Kandi V, Thungaturthi S, Vadakedath S, et al. Mortality rates of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Cureus. 2021;13(3):e14081.
- Naeem U, Eqbal F. Is the hygiene hypothesis a plausible explanation for the asymmetry in COVID-19 mortality? J Pak Med Assoc. 2022;72(4):793.
- Silva Júnior JVJ, Lopes TRR, Weiblen R, et al. Background immunity: how important is it for SARS-CoV-2? J Med Virol. 2021;93(3):1253–1254.
- Finlay BB, Amato KR, Azad M, et al. The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome. Proc Natl Acad Sci USA. 2021;118(6):e2010217118.
- Sonnenburg ED, Smits SA, Tikhonov M, et al. Diet-induced extinctions in the gut microbiota compound over generations. Nature. 2016;529(7585):212–215.
- Sly PD, Trottier BA, Bulka CM, et al. The interplay between environmental exposures and COVID-19 risks in the health of children. Environ Health. 2021;20(1):34.
- Rawson TM, Ming D, Ahmad R, et al. Antimicrobial use, drug-resistant infections and COVID-19. Nat Rev Microbiol. 2020;18(8):409–410.
- Abena PM, Decloedt EH, Bottieau E, et al. Chloroquine and hydroxychloroquine for the prevention or treatment of COVID-19 in Africa: caution for inappropriate off-label use in healthcare settings. Am J Trop Med Hyg. 2020;102(6):1184–1188.
- Bramer CA, Kimmins LM, Swanson R, et al. Decline in child vaccination coverage during the COVID-19 pandemic – Michigan care improvement registry, May 2016–May 2020. Am J Transplant. 2020;20(7):1930–1931.
- Moulson AJ, Av-Gay Y. BCG immunomodulation: from the ‘hygiene hypothesis’ to COVID-19. Immunobiology. 2021;226(1):152052.
- Young A, Neumann B, Mendez RF, et al. Homologous protein domains in SARS-CoV-2 and measles, mumps and rubella viruses: preliminary evidence that MMR vaccine might provide protection against COVID-19. medRxiv. 2020;20053207.
- Sissoko D, Laouenan C, Folkesson E, et al. Experimental treatment with favipiravir for ebola virus disease (the JIKI trial): a historically controlled, Single-Arm proof-of-Concept trial in Guinea. PLoS Med. 2016;13(3):e1001967.